Drugmart Limited

POWER SEARCH PRICING

SOLUTIONS

drugmart limited Company Information

Company Number

06261518

Next Accounts

Jun 2026

Directors

Muhammad Motala

Muhammad Muther

Shareholders

muhammad irfan motala

muhammad muther

Group Structure

View All

Industry

General medical practice activities

Registered Address

78 spotland road, rochdale, lancashire, OL12 6PQ

Website

www.drugmartpharmacy.co.uk

drugmart limited Estimated Valuation

£1.3m

Pomanda estimates the enterprise value of DRUGMART LIMITED at £1.3m based on a Turnover of £2m and 0.63x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Drugmart Limited is a live company located in lancashire, OL12 6PQ with a Companies House number of 06261518. It operates in the general medical practice activities sector, SIC Code 86210. Founded in May 2007, it's largest shareholder is muhammad irfan motala with a 50% stake. Drugmart Limited is a established, small sized company, Pomanda has estimated its turnover at £2m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Drugmart Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating2.5out of 5

2 Strong

5 Regular

4 Weak

Size

annual sales of £2m, make it in line with the average company (£2m)

Growth

3 year (CAGR) sales growth of 24%, show it is growing at a faster rate (10.8%)

EXPORT

Drugmart Limited's latest turnover from September 2024 is estimated at £2 million and the company has net assets of £1.6 thousand. According to their latest financial statements, Drugmart Limited has 20 employees and maintains cash reserves of £92.4 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Turnover	2,046,000	1,119,074	1,663,998	1,060,533	1,024,948	1,037,943	605,363	632,039	1,307,310	1,479,795	1,643,191	1,263,656	798,320	356,265	571,929
Other Income Or Grants
Cost Of Sales	1,085,847	652,618	939,713	636,675	564,230	567,637	301,674	285,367	578,158	732,798	947,982	672,362	385,173	130,303	253,313
Gross Profit	960,153	466,457	724,285	423,858	460,717	470,306	303,689	346,672	729,152	746,998	695,210	591,294	413,148	225,962	318,616
Admin Expenses	920,190	427,437	698,746	422,828	455,162	429,852	294,761	337,857	739,957	727,873	698,292	589,501	408,255	153,401	290,613	73,064
Operating Profit	39,963	39,020	25,539	1,030	5,555	40,454	8,928	8,815	-10,805	19,125	-3,082	1,793	4,893	72,561	28,003	-73,064
Interest Payable	45,928	44,692	31,372	26,251	16,025	8,468	6,385	328	59					232	232
Interest Receivable	5,010	5,613	1,420	15	9	61	65	27	41	85	68	70	222	266	86	8
Pre-Tax Profit	-955	-58	-4,413	-25,206	-10,460	32,048	2,609	8,514	-10,823	19,210	-3,014	1,864	5,114	72,595	27,857	-73,056
Tax						-6,089	-496	-1,618		-3,842		-429	-1,227	-18,875	-7,800
Profit After Tax	-955	-58	-4,413	-25,206	-10,460	25,959	2,113	6,896	-10,823	15,368	-3,014	1,435	3,887	53,720	20,057	-73,056
Dividends Paid
Retained Profit	-955	-58	-4,413	-25,206	-10,460	25,959	2,113	6,896	-10,823	15,368	-3,014	1,435	3,887	53,720	20,057	-73,056
Employee Costs	773,541	552,778	512,316	575,264	633,180	461,493	250,553	273,109	508,048	557,586	650,654	412,452	334,963	137,029	185,682
Number Of Employees	20	16	16	18	19	14	7	8	16	18	22	16	11	5	7
EBITDA*	47,155	45,175	32,511	7,395	11,535	47,120	15,592	15,478	-4,757	24,811	130	5,643	8,743	74,762	29,778	-72,687

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Tangible Assets	135,749	139,319	121,962	128,934	133,249	120,395	126,661	133,325	138,142	142,070	115,192	111,879	90,074	50,622	17,039	4,030
Intangible Assets	425,000	425,000	425,000	425,000	425,000
Investments & Other								126,298	77,023	40,020	40,020	15,580	15,580	5,580
Debtors (Due After 1 year)
Total Fixed Assets	560,749	564,319	546,962	553,934	558,249	120,395	126,661	259,623	215,165	182,090	155,212	127,459	105,654	56,202	17,039	4,030
Stock & work in progress	108,497	98,562	66,473	62,169	81,896	104,941	55,672	55,173	38,117	49,632	65,948	54,515	48,228	46,809	43,088	22,281
Trade Debtors		237		254	559	334	487	550		116,121	98,530	84,474	54,997	15,383	37,544	18,879
Group Debtors
Misc Debtors	253,973	250,540	232,775	349,899	402,299	380,224	357,316	64,399	66,337
Cash	92,393	108,017	105,829	20,432	9,501	9,257	7,124	10,235	11,173	21,379	12,481	14,530	13,641	74,996	31,473	3,078
misc current assets
total current assets	454,863	457,356	405,077	432,754	494,255	494,756	420,599	130,357	115,627	187,132	176,959	153,519	116,866	137,188	112,105	44,238
total assets	1,015,612	1,021,675	952,039	986,688	1,052,504	615,151	547,260	389,980	330,792	369,222	332,171	280,978	222,520	193,390	129,144	48,268
Bank overdraft	45,000	43,333	35,366	49,433	49,433	21,100	110,224	8,620	1,872						7,144
Bank loan
Trade Creditors	297,029	332,896	332,748	329,442	310,654	330,211	297,778	333,549	295,473	350,725	329,042	274,933	217,910	192,667	174,997	113,774
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities	110,948	45,821	60,670	41,920	50,891	168,997	48,311	28,320	19,985
total current liabilities	452,977	422,050	428,784	420,795	410,978	520,308	456,313	370,489	317,330	350,725	329,042	274,933	217,910	192,667	182,141	113,774
loans	350,445	396,275	319,543	356,200	405,633	49,233	70,333
hp & lease commitments
Accruals and Deferred Income
other liabilities	207,642	200,000	200,000	200,000	200,000											7,548
provisions	2,998	845	1,149	2,717	3,711	2,968	3,931	4,921	5,788
total long term liabilities	561,085	597,120	520,692	558,917	609,344	52,201	74,264	4,921	5,788							7,548
total liabilities	1,014,062	1,019,170	949,476	979,712	1,020,322	572,509	530,577	375,410	323,118	350,725	329,042	274,933	217,910	192,667	182,141	121,322
net assets	1,550	2,505	2,563	6,976	32,182	42,642	16,683	14,570	7,674	18,497	3,129	6,045	4,610	723	-52,997	-73,054
total shareholders funds	1,550	2,505	2,563	6,976	32,182	42,642	16,683	14,570	7,674	18,497	3,129	6,045	4,610	723	-52,997	-73,054

	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Operating Activities
Operating Profit	39,963	39,020	25,539	1,030	5,555	40,454	8,928	8,815	-10,805	19,125	-3,082	1,793	4,893	72,561	28,003	-73,064
Depreciation	7,192	6,155	6,972	6,365	5,980	6,666	6,664	6,663	6,048	5,686	3,212	3,850	3,850	2,201	1,775	377
Amortisation
Tax						-6,089	-496	-1,618		-3,842		-429	-1,227	-18,875	-7,800
Stock	9,935	32,089	4,304	-19,727	-23,045	49,269	499	17,056	-11,515	-16,316	11,433	6,287	1,419	3,721	20,807	22,281
Debtors	3,196	18,002	-117,378	-52,705	22,300	22,755	292,854	-1,388	-49,784	17,591	14,056	29,477	39,614	-22,161	18,665	18,879
Creditors	-35,867	148	3,306	18,788	-19,557	32,433	-35,771	38,076	-55,252	21,683	54,109	57,023	25,243	17,670	61,223	113,774
Accruals and Deferred Income	65,127	-14,849	18,750	-8,971	-118,106	120,686	19,991	8,335	19,985
Deferred Taxes & Provisions	2,153	-304	-1,568	-994	743	-963	-990	-867	5,788
Cash flow from operations	65,437	-19,921	166,073	88,650	-124,640	121,163	-295,027	43,736	27,063	41,377	28,750	26,473	-8,274	91,997	43,729	-73
Investing Activities
capital expenditure	-3,622	-23,512		-2,050	-443,834	-400		-1,846	-2,120	-32,564	-6,525	-25,655	-43,302	-35,784	-14,784	-4,407
Change in Investments							-126,298	49,275	37,003		24,440		10,000	5,580
cash flow from investments	-3,622	-23,512		-2,050	-443,834	-400	126,298	-51,121	-39,123	-32,564	-30,965	-25,655	-53,302	-41,364	-14,784	-4,407
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans	-45,830	76,732	-36,657	-49,433	356,400	-21,100	70,333
Hire Purchase and Lease Commitments
other long term liabilities	7,642				200,000										-7,548	7,548
share issue											98					2
interest	-40,918	-39,079	-29,952	-26,236	-16,016	-8,407	-6,320	-301	-18	85	68	70	222	34	-146	8
cash flow from financing	-79,106	37,653	-66,609	-75,669	540,384	-29,507	64,013	-301	-18	85	166	70	222	34	-7,694	7,558
cash and cash equivalents
cash	-15,624	2,188	85,397	10,931	244	2,133	-3,111	-938	-10,206	8,898	-2,049	889	-61,355	43,523	28,395	3,078
overdraft	1,667	7,967	-14,067		28,333	-89,124	101,604	6,748	1,872					-7,144	7,144
change in cash	-17,291	-5,779	99,464	10,931	-28,089	91,257	-104,715	-7,686	-12,078	8,898	-2,049	889	-61,355	50,667	21,251	3,078

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for drugmart limited. Get real-time insights into drugmart limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for drugmart limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in OL12 area or any other competitors across 12 key performance metrics.

DRUGMART LIMITED group structure

Drugmart Limited has no subsidiary companies.

Ultimate parent company

DRUGMART LIMITED

06261518

DRUGMART LIMITED Shareholders

muhammad irfan motala	50%
muhammad muther	50%

Drugmart Limited currently has 2 directors. The longest serving directors include Mr Muhammad Motala (May 2007) and Mr Muhammad Muther (May 2007).

officer	country	age	start	end	role
Mr Muhammad Motala	United Kingdom	50 years	May 2007	-	Director
Mr Muhammad Muther	England	53 years	May 2007	-	Director

P&L

September 2024

turnover

+83%

operating profit

40k

gross margin

47%

+12.59%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

September 2024

net assets

1.6k

-0.38%

total assets

-0.01%

cash

92.4k

-0.14%

net assets

Total assets minus all liabilities

Similar Companies

al tawfiq ltd

pspd limited

lmk healthcare provision ltd

phoenix health warrington limited

2.5

rajkumar padmakumar limited

4.5

company number

06261518

Type

Private limited with Share Capital

industry

86210 - General medical practice activities

incorporation date

May 2007

ultimate parent company

None

previous names

N/A

address

78 spotland road, rochdale, lancashire, OL12 6PQ

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 5 charges/mortgages relating to drugmart limited. Currently there are 2 open charges and 3 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for DRUGMART LIMITED. This can take several minutes, an email will notify you when this has completed.

drugmart limited Company Information

drugmart limited Estimated Valuation

drugmart limited Estimated Valuation

drugmart limited Estimated Valuation

Drugmart Limited Overview

Drugmart Limited Health Check

DRUGMART LIMITED financials

drugmart limited Credit Report and Business Information

Drugmart Limited Competitor Analysis

drugmart limited Ownership

drugmart limited directors

drugmart limited company details

drugmart limited Charges & Mortgages

drugmart limited Capital Raised & Share Issues BETA

drugmart limited Companies House Filings - See Documents